 |
02.06.2010
ESC 2010 Barcelona
BrainsGate attends the ESC 2010 in Barcelona read more |
 |
03.03.2010
ISC 2010 San Antonio, TX
BrainsGate attends the International Stroke Conference (ISC) 2010 in San Antonio, TX read more |
 |
18.01.2010
ANIM 2010 Bad Homburg, Germany
BrainsGate attends the German ANIM meeting for the first time read more |
 |
28.08.2009
World Innovation Summit
BrainsGate invited to speak at the third World Innovation Summit in Tel Aviv, September 14. read more |
 |
19.08.2009
Nordic Stroke 2009
BrainsGate sponsors the 15th Nordic Congress on Cerebrovascular Diseases, 19-22 August 2009, Helsinki, Finland read more |
 |
16.06.2009
BioMed 2009
BrainsGate attends the BioMed 2009 in Tel Aviv read more |
 |
26.05.2009
ESC 2009
BrainsGate attends the ESC 2009 in Stockholm read more |
 |
18.02.2009
BrainsGate at ASA 2009
BrainsGate's booth was bigger and better than last year read more |
 |
25.09.2008
BrainsGate launches ImpACT-24
ImpACT-24 is a randomized, sham-controlled, double blind study to test the safety and efficacy of BrainsGate's ISS for treatment of acute ischemic stroke victims in a 24 hour window read more |
 |
20.02.2008
AHA Stroke conference
BrainsGate launches its pivotal trial, ImpACT-24 in New Orleans read more |
 |
06.06.2007
BioMed 2007
BrainsGate attends BioMed 2007 in Tel-Aviv read more |
 |
29.05.2006
BioMed 2006
BrainsGate attends BioMed 2006 in Jerusalem read more |
 |
09.04.2006
Bio 2006
BrainsGate attends Bio 2006 in Chicago read more |
 |
16.02.2006
International Stroke meeting 2006
BrainsGate attended and presented a poster read more |
|
January 18, 2010
ANIM 2010 Bad Homburg, Germany
BrainsGate attends the German ANIM meeting for the first time > full story
September 25, 2008
BrainsGate launches ImpACT-24
ImpACT-24 is a randomized, sham-controlled, double blind study to test the safety and efficacy of BrainsGate's ISS for treatment of acute ischemic stroke victims in a 24 hour window > full story
|
Login
